CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 83 enrolled
Drug / intervention
NaF +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01128946
NCT01128946Phase 4Completed

Comparison of Enamel Remineralization Potential of Dentifrices Incorporating Different Fluoride Salts Using an in Situ Caries Model

GlaxoSmithKline·interventional·Posted May 24, 2010·Updated Jan 1, 2015

In Brief

A Phase 4 clinical trial evaluating NaF, SnF, and 1 other intervention for Dental Caries. Completed, enrolled 83 participants across 1 site.

Detailed Summary

This study will use an oral in-situ caries model to study remineralization of enamel due to the action of different combinations of fluoride salts delivered from dentifrices.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Caries
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 24, 2010
Enrollment StartNov 1, 2009
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 16.1 years ago

Interventions

NaFdrug

Fluoride toothpaste containing sodium fluoride as 1450 parts per million (ppm) F, 675 ppmF, 450 ppmF, 350ppmF.

SnFdrug

Fluoride toothpaste containing stannous fluoride (1100 ppmF)

NaMFPdrug

Fluoride toothpaste containing sodium monofluorophosphate (1000 ppmF)